AHRQ Comparative Research Should Focus On Diseases, Not Drug Classes, PhRMA Says

Outcomes research priority should be treatment options for diseases with a high prevalence among Medicare and Medicaid beneficiaries, PhRMA says. Payor comments specify therapeutic classes where comparative data is needed most.